Overview

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Status:
RECRUITING
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
We investigate the role of empagliflozin in the treatment of obesity in PLWH.
Phase:
PHASE2
Details
Lead Sponsor:
Abdelrahman Mahmoud
Treatments:
empagliflozin